BNP/CALL/ASTRAZENECA/12000/0.1/21.06.24 Stock

DE000PC3BUR2

Market Closed - Boerse Frankfurt Warrants 11:20:56 2024-05-31 am EDT
0.43 ^EUR	+26.47%

1 month	-21.82%
3 months	+616.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ASTRAZENECA PLC

Chart BNP/CALL/ASTRAZENECA/12000/0.1/21.06.24

Latest news about ASTRAZENECA PLC

Health Care Stocks Climb On Drug News -- Health Care Roundup	May. 31	DJ
Fusion Pharmaceuticals Gets Court Order Approving AstraZeneca Deal	May. 31	MT
News Highlights: Top Company News of the Day - Friday at 1 PM ET	May. 31	DJ
News Highlights : Top Company News of the Day - Friday at 11 AM ET	May. 31	DJ

More news

Quotes 5-day view

Date	Price	Change
24-05-31	0.43	+26.47%
24-05-30	0.34	+30.77%
24-05-29	0.26	-18.75%
24-05-28	0.32	-44.83%
24-05-24	0.58	-13.43%

Real-time Boerse Frankfurt Warrants

Last update May 31, 2024 at 11:20 am EDT

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	ASTRAZENECA PLC
Issuer	BNP Paribas
WKN	PC3BUR
ISIN	DE000PC3BUR2
Date issued	2024-01-16
Strike	12,000 p
Maturity	2024-06-21 (20 Days)
Parity	10 : 1
Emission price	0.24 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.79 €
Lowest since issue	0.018 €
Spread	0.02 €
Spread %	4.44%

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).

Sector

More about the company